Back to Search
Start Over
Supplementary Data from A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non–small Cell Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplement
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....487d7d4f227be75a79f5363a442f9217
- Full Text :
- https://doi.org/10.1158/1078-0432.22480679.v1